The Latest
-
Moleculin Pops 33% On Anti-Viral Activity For Potential Covid-19 Treatment
-
Goldman Sachs: These 2 Stocks Are Poised to Soar by at Least 50%
-
An Intrinsic Calculation For OPKO Health, Inc. (NASDAQ:OPK) Suggests It’s 36% Undervalued
-
Has Skyworks Solutions (NASDAQ:SWKS) Got What It Takes To Become A Multi-Bagger?